Kozyra, E. J., Pastor, V. B., Lefkopoulos, S., Sahoo, S. S., Busch, H., Voss, R. K., Erlacher, M., Lebrecht, D., Szvetnik,
E. A., Hirabayashi, S., Pasaulienė, R., Pedace, L., Tartaglia, M., Klemann, C., Metzger, P., Boerries, M., Catala, A., Hasle,
H., de Haas, V., Kállay, K., Masetti, R., Moerloose, B. D., Dworzak, M., Schmugge, M., Smith, O., Starý, J., Mejstrikova,
E., Ussowicz, M., Morris, E., Singh, P., Collin, M., Dereka, M., Göhring, G., Flotho, C., Strahm, B., Locatelli, F., Niemeyer,
C. M., Trompouki, E., Wlodarski, M. W., & EWOG-MDS, W. G. (2020). Synonymous GATA2
mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency.
Leukemia: the Journal of Normal and Malignant Hemopoiese; Official Journal of the Leukemia Research Fund U.K.,
34, 2673-2687.